Saugel, B;Phillip, V;Moessmer, G;Schmid, RM;Huber, W.Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study..Crit Care.2010.14.3.R90

Steimer, W.Pharmacogenetics and psychoactive drug therapy: ready for the patient?.Ther Drug Monit.2010.32.4.381-6

Müller, C;Schlichtiger, A;Balling, G;Steigerwald, U;Luppa, PB;Thaler, M.Standardized antigen preparation to achieve comparability of anti-beta2-glycoprotein I assays..Thromb Res.2010.126.2.e102-9

Luppa, PB;Metzger, J;Schneider, H.Surface plasmon resonance biosensorics in urine proteomics..Methods Mol Biol.2010.641.193-221

Hofmann, W;Sedlmeir-Hofmann, C;Ivandi?, M;Ruth, D;Luppa, P.PROTIS: use of combined biomarkers for providing diagnostic information on disease states..Methods Mol Biol.2010.641.123-42

Müller, C;Thaler, M;Schlichtiger, A;Schreiegg, A;Balling, G;Steigerwald, U;Luppa, PB.?2-glycoprotein I-derived peptides as antigenic structures for the detection of antiphospholipid antibodies..J Thromb Haemost.2010.8.9.2073-5

Junker, R;Schlebusch, H;Luppa, PB.Point-of-care testing in hospitals and primary care..Dtsch Arztebl Int.2010.107.33.561-7

Mielsch, C;Zimmermann, A;Wagner, D;Matthes, B;Schlebusch, H;Luppa, PB.Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265..Clin Chem Lab Med.2010.48.10.1455-61

Roos, M;Oikonomou, D;von Eynatten, M;Luppa, PB;Heemann, U;Lutz, J;Baumann, M;Nawroth, PP;Bierhaus, A;Humpert, PM.Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy..Cardiovasc Diabetol.2010.9.48

Paslakis, G;Luppa, P;Gilles, M;Kopf, D;Hamann-Weber, B;Lederbogen, F;Deuschle, M.Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment..J Psychiatr Res.2010.44.8.556-560